Drug intelligence / Profile preview

Ther-Biotic Synbiotic

Development stage: Unknown
Lead developer: SFI Health
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Ther-Biotic Synbiotic is a shelf-stable, hypoallergenic dietary supplement developed by SFI Health (formerly Soho Flordis International) and marketed under the Klaire Labs brand. It is a synbiotic formulation that combines 50 billion colony-forming units (CFU) of seven clinically documented probiotic strains with SunFiber, a low-FODMAP certified prebiotic derived from partially hydrolyzed guar gum. The product utilizes delayed-release capsule technology to ensure the survival of the probiotic strains through the stomach for optimal delivery to the gastrointestinal tract. It is indicated for the support of gastrointestinal ecology, immune system function, and respiratory health, as well as the relief of occasional GI discomfort.

Brand names: Ther-Biotic Synbiotic
Other names: Klaire Labs Ther-Biotic Synbiotic

Beyond the preview

Go deeper on Ther-Biotic Synbiotic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ther-Biotic Synbiotic.

Explore the full profile